Page 233 - Read Online

Giorgio et al. Hepatoma Res 2019;5:20 I http://dx.doi.org/10.20517/2394-5079.2019.05 Page 9 of 9

31. Jang HJ, Kim TK, Burns PN, Wilson SR. CEUS: an essential component in a multimodality approach to small nodules in patients at
high-risk for hepatocellular carcinoma Eur J Radiol 2015;84:1623-35.
32. Kono Y, Lyshchik A, Cosgrove D, Dietrich CF, Jang HJ, et al. Contrast enhanced ultrasound (CEUS) liver imaging reporting and data
system (LI-RADS(R)): the official version by the american college of radiology (ACR). Ultraschall Med 2017;38:85-6.
33. Piscaglia F, Wilson SR, Lyshchik A, Cosgrove D, Dietrich CF, et al. American college of radiology contrast enhanced ultrasound liver
imaging reporting and data system (CEUS LI-RADS) for the diagnosis of hepatocellular carcinoma: a pictorial essay. Ultraschall Med
2017;38:320-4.
34. Tae Kyoung Kim, Seung Yeon Noh, Stephanie R Wilson, Yuko Kono, Fabio Piscaglia, et al. Contrast-enhanced ultrasound (CEUS) liver
imaging reporting and data system (LI-RADS) 2017 - a review of important differences compared to the CT/MRI system. Clin Mol
Hepatol 2017;23:280-9.
35. Dietrich CF, Potthoff A, Helmberger T, Ignee A, Willmann JK, et al. Contrast-enhanced ultrasound: liver imaging reporting and data
system (CEUS LI-RADS)]. Z Gastroenterol 2018;56:499-506. (in German)
36. Terzi E, Iavarone M, Pompili M, Veronese L, Cabibbo G, et al. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in
cirrhosis in a multicenter restropective study of 1,006 nodules; CEUS LI-RADS Italy study group collaborators. J Hepatol 2018;68:485-
92.
37. Yang D, Li R, Tang CL, Ma KS, Guo DY, et al. Perfusion characteristics of hepatocellular carcinoma at contrast-enhanced ultrasound:
influence of the cellular differentiation, the tumor size and the underlying hepatic condition. Sci Rep 2018;8:4713.
38. Schellhaas B, Hammon M, Strobel D, Pfeifer L, Kielisch C, et al. Interobserver and intermodality agreement of standardized algorithms
for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS. Eur Radiol
2018;28:4254-64.
39. Schellhaas B, Pfeifer L, Kielisch C, Goertz RS, Neurath MF, et al. Interobserver agreement for contrast-enhanced ultrasound (CEUS)-
based standardized algorithms for the diagnosis of hepatocellular carcinoma in high-risk patients. Ultraschall Med 2018;39:667-74.
40. Giorgio A, Montesarchio L, Gatti P, Amendola F, Matteucci P, et al. Contrast-enhanced ultrasound: a simple and effective tool in
defining a rapid diagnostic work-up for small nodules detected in cirrhotic patients during surveillance. J Gastrointestin Liver Dis
2016;25:205-11.
41. Ling W, Wang M, Ma X, Qiu T, Li J, et al. The preliminary application of liver imaging reporting and data system (LI-RADS) with
contrast-enhanced ultrasound (CEUS) on small hepatic nodules (≤ 2cm). J Cancer 2018;9:2946-52.
42. Giorgio A, Calisti G, di Sarno A, Farella N, de Stefano G, et al. Characterization of dysplastic nodules, early hepatocellular carcinoma
and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ultrasound. Anticancer Res 2011;31:3977-82.
43. Aubé C, Oberti F, Lonjon J, Pageaux G, Seror O, et al. EASL and AASLD recommendations for the diagnosis of HCC to the test of daily
practice. Liver Int 2017;37:1515-25.
44. Moudgil S, Kalra N, Prabhakar N, Dhiman RK, Behera A, et al. Comparison of contrast enhanced ultrasound with contrast enhanced
computed tomography for the diagnosis of hepatocellular carcinoma. J Clin Exp Hepatol 2017;7:222-9.
45. Huf S, Platz Batista da Silva N, Wiesinger I, Hornung M, Scherer MN, et al. Analysis of liver tumors using preoperative and intraoperative
contrast-enhanced ultrasound (CEUS/IOCEUS) by radiologists in comparison to magnetic resonance imaging and histopathology. Rofo
2017;189:431-40.
46. Seitz K, Strobel D. A milestone: approval of CEUS for diagnostic liver imaging in adults and children in the USA. Ultraschall Med
2016;37:229-32.